RxDoctor Payments Data

Tess Jones

Physician Assistant · Reno, NVNPI 1285256107

Payments from drug & device makers

$1,538in general payments, 2019–2025

Across 26 payments — averaging $59.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$996
  • AbbVie$98
  • Astellas Pharma US Inc$85
  • Teleflex LLC$77
  • Boston Scientific$75
  • AstraZeneca$66
  • plus $142 from 5 others

What the payments were for

  • Travel & lodging$76850%
  • Food & beverage$65843%
  • Education$1127%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,538 in reported general payments places this provider in the 70th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada

Medicare billing

Part B allowed, 2024
$78,437
Medicare patients
587
Services billed
1,403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron105$97,429
GemtesaVibegron75$72,497
Tamsulosin Hcl313$5,551
Testosterone Cypionate49$2,618
Tolterodine Tartrate ErTolterodine Tartrate23$2,402
Estradiol16$2,091
Potassium Citrate ErPotassium Citrate21$2,075
Solifenacin Succinate37$2,048
Finasteride93$1,527
Tadalafil21$1,457
Trospium Chloride40$1,395
NitrofurantoinNitrofurantoin Macrocrystal39$1,316
Oxybutynin Chloride ErOxybutynin Chloride46$1,076
Silodosin11$1,044
Testosterone12$799

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$85$97,429105 claims
Sumitomo Pharma America, Inc.Gemtesa$14$72,49775 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 881 physician assistant providers in Nevada.

Other physician assistant in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →